ABG

Ally Bridge Group Portfolio holdings

AUM $114M
1-Year Est. Return 41.64%
This Quarter Est. Return
1 Year Est. Return
+41.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
+$11.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$10.1M
2
+$4.93M
3
+$4.91M
4
SLNO icon
Soleno Therapeutics
SLNO
+$4.89M
5
CMPS
Compass Pathways
CMPS
+$4.16M

Top Sells

1
+$12.4M
2
+$8.41M
3
+$6.57M
4
TRVI icon
Trevi Therapeutics
TRVI
+$4.32M
5
INSM icon
Insmed
INSM
+$3.76M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
26
CG Oncology
CGON
$3.16B
– –
-132,298
CNTX icon
27
Context Therapeutics
CNTX
$129M
– –
-1,157,448
DNTH icon
28
Dianthus Therapeutics
DNTH
$1.42B
– –
-80,584
EWTX icon
29
Edgewise Therapeutics
EWTX
$1.59B
– –
-102,650
JANX icon
30
Janux Therapeutics
JANX
$1.61B
– –
-81,292
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$3.15B
– –
0
SWTX
32
DELISTED
SpringWorks Therapeutics
SWTX
– –
-281,139
TRVI icon
33
Trevi Therapeutics
TRVI
$1.26B
– –
-686,219
TYRA icon
34
Tyra Biosciences
TYRA
$773M
– –
-107,244
XENE icon
35
Xenon Pharmaceuticals
XENE
$3.21B
– –
-69,603
1
2